Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 2 de 2
1.
ACS Nano ; 16(4): 6080-6092, 2022 04 26.
Article En | MEDLINE | ID: mdl-35412309

Nanoparticles need to navigate a complex microenvironment to target cells in solid tumors after extravasation. Diffusion is currently the accepted primary mechanism for nanoparticle distribution in tumors. However, the extracellular matrix can limit nanoparticle diffusion. Here, we identified tumor-associated macrophages as another key player in transporting and redistributing nanoparticles in the tumor microenvironment. We found tumor-associated macrophages actively migrate toward nanoparticles extravasated from the vessels, engulfing and redistributing them in the tumor stroma. The macrophages can carry the nanoparticles 2-5 times deeper in the tumor than passive diffusion. The amount of nanoparticles transported by the tumor-associated macrophages is size-dependent. Understanding the nanoparticle behavior after extravasation will provide strategies to engineer them to navigate the microenvironment for improved intratumoral targeting and therapeutic effectiveness.


Nanoparticles , Neoplasms , Humans , Cell Line, Tumor , Nanoparticles/therapeutic use , Neoplasms/drug therapy , Tumor Microenvironment , Macrophages/pathology , Drug Delivery Systems
2.
Nano Lett ; 20(2): 1362-1369, 2020 02 12.
Article En | MEDLINE | ID: mdl-31928014

Three-dimensional (3D) optical microscopy can be used to understand and improve the delivery of nanomedicine. However, this approach cannot be performed for analyzing liposomes in tissues because the processing step to make tissues transparent for imaging typically removes the lipids. Here, we developed a tag, termed REMNANT, that enables 3D imaging of organic materials in biological tissues. We demonstrated the utility of this tag for the 3D mapping of liposomes in intact tissues. We also showed that the tag is able to monitor the release of entrapped therapeutic agents. We found that liposomes release their cargo >100-fold faster in tissues in vivo than in conventional in vitro assays. This allowed us to design a liposomal formulation with enhanced ability to kill tumor associated macrophages. Our development opens up new opportunities for studying the chemical properties and pharmacodynamics of administered organic materials in an intact biological environment. This approach provides insight into the in vivo behavior of degradable materials, where the newly discovered information can guide the engineering of the next generation of imaging and therapeutic agents.


Diagnostic Imaging/methods , Nanoparticles/chemistry , Neoplasms/drug therapy , Animals , Humans , Imaging, Three-Dimensional , Lipids/chemistry , Liposomes/chemistry , Liposomes/pharmacology , Mice , Nanomedicine , Neoplasms/pathology , Tumor-Associated Macrophages/drug effects
...